Foley Attorneys Publish on Telemedicine Considerations for Decentralized Clinical Trials
January 14, 2025
Applied Clinical Trials
Foley & Lardner LLP attorneys Jessica Warwick, Kyle Faget, and Monica Chmielewski authored the Applied Clinical Trials article, “Telemedicine Considerations When Conducting Decentralized Clinical Trials.”
“Decentralized clinical trials (DCTs) involve some or all trial-related activities conducted at locations other than traditional clinical trial sites, such as via telemedicine or in a clinical trial participant’s home,” the authors write. “The use of telemedicine in DCTs implicates various state legal and regulatory considerations as the performance of research, or the performance of certain procedures within a clinical trial, may and often fall within and are deemed to be the ‘practice of medicine.'”
People
Related News
January 6, 2026
In the News
Kyle Faget Weighs in on Pharmaceutical Industry Legal Battles
Foley & Lardner LLP partner Kyle Faget shared insight with Law360 on major legal topics affecting the pharmaceutical industry.
January 2, 2026
In the News
Judith Waltz Shares Insights on Key Health Law Developments on AHLA Podcast
Foley & Lardner LLP partner Judith Waltz hosted the American Health Law Association's Speaking of Health Law podcast to discuss major health law developments from 2025 and offer insights on trends expected in 2026.
January 2, 2026
In the News
Rajiv Dharnidharka Examines Trade Secret Litigation Trends
Foley & Lardner LLP partner Rajiv Dharnidharka commented on anticipated developments in trade secret law this year in the Law360 article, “Trade Secret Trends To Watch In 2026.”